Management of high-risk subsets in unstable angina
1Department of Internal Medicine, Northwestern University, McGaw Medical Center, Chicago, Illinois, USA.
Insights
This article reviews optimal treatment for refractory angina post-heart attack, emphasizing an aggressive early strategy including coronary angiography and revascularization. It highlights the role of glycoprotein IIb-IIIa antagonists in managing unstable angina.
Area of Science:
- Cardiology
- Clinical Trials
- Pharmacology
Background:
- Postinfarction, refractory, or recurrent angina requires optimal treatment strategies.
- Unstable angina management necessitates special considerations for high-risk patient subsets.
Purpose of the Study:
- To outline the optimal treatment for postinfarction, refractory, or recurrent angina.
- To emphasize special considerations for high-risk subsets within unstable angina management.
- To highlight the role of emerging therapies like glycoprotein IIb-IIIa antagonists.
Main Methods:
- Review of recent clinical trials.
- Analysis of acute medical management strategies.
- Emphasis on early coronary angiography and revascularization.
Main Results:
- An early aggressive strategy involving coronary angiography and revascularization is recommended for high-risk subsets.
- Platelet inhibition, particularly with glycoprotein IIb-IIIa antagonists, plays a crucial role in managing unstable angina.
Conclusions:
- Optimal treatment for refractory angina involves an aggressive, early interventional approach.
- Glycoprotein IIb-IIIa antagonists represent a significant advancement in managing unstable angina due to their effect on platelet aggregation.
Abstract:
This article focuses on the optimal treatment of postinfarction, refractory, or recurrent angina based on the results of recent clinical trials. Many of our recommendations hold true for the general management of unstable angina, but special considerations for the high-risk subsets are emphasized. Specifically, we discuss acute medical management and suggest that an early aggressive strategy that leads to early coronary angiography with the goal of revascularization when feasible best serves this subset. A special emphasis on the emerging role of glycoprotein IIb-IIIa antagonists is made because the important role of platelets in coronary thrombosis has dominated recent views on the pathophysiology of unstable angina.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Angina IV: Management
Angina V: Nursing Management
